#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Glioblastoma Chronic myeloid leukaemia (in remission) Lymphangioma Neuropathic arthropathy Cardiomyopathy Juvenile idiopathic arthritis Infantile apnoea Juvenile chronic myelomonocytic leukaemia Acquired haemophilia Dent's disease Adenomatous polyposis coli Ehlers-Danlos syndrome Rhabdomyosarcoma recurrent Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome Mucous membrane pemphigoid – Treatment Glomerulonephritis rapidly progressive – Diagnostics Uterine leiomyosarcoma – Treatment Paroxysmal nocturnal haemoglobinuria – Trials in Disease Cystic fibrosis – Basic Information Idiopathic pulmonary fibrosis – Treatment Ornithine transcarbamoylase deficiency – Life with Disease Leiomyosarcoma – Life with Disease Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tisagenlecleucel Bi-1808 Morphine Sulfate Tigulixostat Brentuximab Vedotin ANOC-001 Human Apotransferrin Zolbetuximab Ht-29-B Pristinamycin Mps-216 Amoxicillin Sodium Mecasermin Rinfabate Caraway Oil AZD4512 GSKVX000000070250 Mebendazole Tarlatamab Skin Autograft Emibetuzumab More therapies…

    Learn about Your Condition

    Drug use disorder Rhabdomyosarcoma recurrent Procedural haemorrhage Hypothyroidism Pancreatitis chronic Desmoplastic melanoma Anaemia of pregnancy Precocious puberty Usher's syndrome Varicella Subarachnoid haemorrhage Gastric cancer recurrent Vulval cancer recurrent Acne Transplantation complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sjogren’s syndrome

  • Study on the Effects of Ianalumab in Patients with Sjögren’s Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • ARTICAINE HYDROCHLORIDE
    • Epinephrine Bitartrate
    • Entecavir
    France

  • Title: Study of Sibeprenlimab Treatment for Adults with Sjögren’s Disease Using Subcutaneous Injections

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Sibeprenlimab
    Bulgaria Germany Greece Poland Romania Spain

  • Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Estonia France Germany +12

  • Study on the Effects of Abiprubart for Patients with Sjögren’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Kpl-404
    Czechia France Germany Hungary Poland Spain

  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dry eye
    • Rheumatoid arthritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Czechia Germany Hungary Italy The Netherlands Poland +1

  • Study on the Effectiveness of Human Normal Immunoglobulin for Treating Painful Nerve Damage in Patients with Primary Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Sodium Chloride Solution 0.9%
    • Human Normal Immunoglobulin
    France
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!